| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 2.07e-08 | 14 | 130 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.32e-07 | 23 | 130 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 1.13e-06 | 29 | 130 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.13e-06 | 29 | 130 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.59e-06 | 34 | 130 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.64e-05 | 49 | 130 | 5 | GO:0051861 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 9.34e-05 | 70 | 130 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.14e-04 | 73 | 130 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 3.06e-04 | 90 | 130 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 4.35e-04 | 149 | 130 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | IL17REL GPR63 RET PTCH1 ACKR4 FZD7 OR56B1 OR10G3 OR10G2 PLXNC1 TAS1R2 NCR2 ANXA9 ADGRL2 FZD2 IL3RA PALLD PTGDR2 ADGRA3 PLXNB3 | 4.68e-04 | 1353 | 130 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 1.20e-03 | 398 | 130 | 9 | GO:0046982 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 9.29e-10 | 18 | 129 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 6.53e-09 | 24 | 129 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.69e-08 | 14 | 129 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.25e-08 | 29 | 129 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 2.53e-08 | 15 | 129 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 2.53e-08 | 15 | 129 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.53e-08 | 15 | 129 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.53e-08 | 15 | 129 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 3.66e-08 | 16 | 129 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 5.16e-08 | 17 | 129 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 5.16e-08 | 17 | 129 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 5.16e-08 | 17 | 129 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.27e-07 | 20 | 129 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.66e-07 | 21 | 129 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.66e-07 | 21 | 129 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.66e-07 | 21 | 129 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.72e-07 | 40 | 129 | 6 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.00e-07 | 41 | 129 | 6 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.14e-07 | 22 | 129 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 2.48e-07 | 69 | 129 | 7 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.72e-07 | 23 | 129 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.72e-07 | 23 | 129 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.75e-07 | 70 | 129 | 7 | GO:1900047 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.85e-07 | 187 | 129 | 10 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 3.34e-07 | 72 | 129 | 7 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 3.42e-07 | 24 | 129 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 3.42e-07 | 24 | 129 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 4.25e-07 | 25 | 129 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 4.25e-07 | 25 | 129 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 4.63e-07 | 47 | 129 | 6 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 4.63e-07 | 47 | 129 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 6.40e-07 | 27 | 129 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 7.75e-07 | 28 | 129 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 8.56e-07 | 52 | 129 | 6 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.32e-06 | 31 | 129 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.56e-06 | 32 | 129 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.56e-06 | 32 | 129 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.56e-06 | 32 | 129 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 1.66e-06 | 91 | 129 | 7 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.83e-06 | 33 | 129 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.83e-06 | 33 | 129 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 1.93e-06 | 93 | 129 | 7 | GO:1900046 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.13e-06 | 34 | 129 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.13e-06 | 34 | 129 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 2.39e-06 | 96 | 129 | 7 | GO:0050818 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.47e-06 | 35 | 129 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 2.74e-06 | 98 | 129 | 7 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 3.77e-06 | 38 | 129 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 4.30e-06 | 39 | 129 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 6.25e-06 | 42 | 129 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 6.43e-06 | 73 | 129 | 6 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 7.51e-06 | 114 | 129 | 7 | GO:0045824 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 8.13e-06 | 76 | 129 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 8.85e-06 | 45 | 129 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 9.88e-06 | 46 | 129 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 9.88e-06 | 46 | 129 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.10e-05 | 80 | 129 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.10e-05 | 47 | 129 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.30e-05 | 124 | 129 | 7 | GO:0001910 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.35e-05 | 49 | 129 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.35e-05 | 49 | 129 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.36e-05 | 83 | 129 | 6 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.45e-05 | 126 | 129 | 7 | GO:1903035 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.50e-05 | 50 | 129 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.57e-05 | 232 | 129 | 9 | GO:0002706 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 1.80e-05 | 236 | 129 | 9 | GO:0042129 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 2.00e-05 | 53 | 129 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | 2.01e-05 | 301 | 129 | 10 | GO:0050670 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | 2.31e-05 | 306 | 129 | 10 | GO:0032944 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 2.35e-05 | 187 | 129 | 8 | GO:0001909 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 2.43e-05 | 375 | 129 | 11 | GO:0007162 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.62e-05 | 56 | 129 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.81e-05 | 313 | 129 | 10 | GO:0098742 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 3.12e-05 | 96 | 129 | 6 | GO:0002704 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 3.38e-05 | 59 | 129 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 3.67e-05 | 60 | 129 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 3.67e-05 | 60 | 129 | 5 | GO:0045922 | |
| GeneOntologyBiologicalProcess | bone resorption | 3.71e-05 | 99 | 129 | 6 | GO:0045453 | |
| GeneOntologyBiologicalProcess | blood coagulation | 3.85e-05 | 260 | 129 | 9 | GO:0007596 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 3.92e-05 | 147 | 129 | 7 | GO:0031341 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 3.98e-05 | 61 | 129 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | endothelial cell migration | 4.50e-05 | 331 | 129 | 10 | GO:0043542 | |
| GeneOntologyBiologicalProcess | coagulation | 4.59e-05 | 266 | 129 | 9 | GO:0050817 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | 4.62e-05 | 332 | 129 | 10 | GO:0070663 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 4.65e-05 | 151 | 129 | 7 | GO:0002832 | |
| GeneOntologyBiologicalProcess | hemostasis | 4.87e-05 | 268 | 129 | 9 | GO:0007599 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 5.17e-05 | 105 | 129 | 6 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 5.74e-05 | 107 | 129 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 5.83e-05 | 66 | 129 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 6.20e-05 | 158 | 129 | 7 | GO:0045446 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 6.27e-05 | 67 | 129 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 6.37e-05 | 109 | 129 | 6 | GO:0002228 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | HSPG2 ABI3BP PSG1 PSG3 PSG4 PSG9 EFEMP2 VSIG4 RET ZP3 FZD7 EFNB1 TENM3 PLXNC1 PSG8 PLG PLXNB3 | 6.69e-05 | 927 | 129 | 17 | GO:0030155 |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | SEMA3F PSG1 PSG3 PSG4 LEMD3 PSG9 RET EFNB1 FSTL1 CD40 PSG8 PLG TNS3 | 6.82e-05 | 577 | 129 | 13 | GO:0001667 |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 7.74e-05 | 70 | 129 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 8.28e-05 | 71 | 129 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 8.28e-05 | 71 | 129 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 8.46e-05 | 288 | 129 | 9 | GO:0042098 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 8.46e-05 | 166 | 129 | 7 | GO:0002698 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 8.46e-05 | 166 | 129 | 7 | GO:0061041 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 3.56e-08 | 16 | 130 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | cell surface | PSG1 PSG3 PSG4 PSG7 PSG9 HLA-F BCAN ACKR4 EFNB1 UMODL1 CD40 PSG8 DEFB126 PLG NCR2 ANXA9 IL3RA ADGRA3 PLXNB3 CA4 | 1.73e-05 | 1111 | 130 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | PSG1 PSG3 PSG4 PSG9 HLA-F ACKR4 UMODL1 CD40 PSG8 PLG IL3RA ADGRA3 CA4 | 2.18e-05 | 519 | 130 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | ciliary membrane | 3.40e-05 | 98 | 130 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | glycocalyx | 3.84e-05 | 2 | 130 | 2 | GO:0030112 | |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 ABI3BP CTSC EFEMP2 RPSA BCAN ZP3 PKHD1L1 F9 COL24A1 DEFB126 PLG ANXA9 OTOG | 6.19e-05 | 658 | 130 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | receptor complex | PSG1 PSG3 PSG4 PSG9 GPR63 RET PLXNC1 ARNT2 CD40 TAS1R2 PSG8 IL3RA PLXNB3 | 6.93e-05 | 581 | 130 | 13 | GO:0043235 |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.48e-04 | 90 | 130 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | side of membrane | PSG1 PSG3 PSG4 PSG9 HLA-F BCAN XPNPEP2 ACKR4 UMODL1 CD40 PSG8 PLG IL3RA ADGRA3 CA4 | 3.59e-04 | 875 | 130 | 15 | GO:0098552 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.82e-04 | 530 | 130 | 11 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 ABI3BP CTSC EFEMP2 RPSA BCAN ZP3 F9 COL24A1 PLG ANXA9 OTOG | 8.16e-04 | 656 | 130 | 12 | GO:0031012 |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.44e-07 | 17 | 108 | 5 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 4.62e-07 | 21 | 108 | 5 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 9.48e-07 | 24 | 108 | 5 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 1.77e-06 | 27 | 108 | 5 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.14e-06 | 28 | 108 | 5 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 3.63e-06 | 31 | 108 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 3.63e-06 | 31 | 108 | 5 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 6.77e-06 | 35 | 108 | 5 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 7.81e-06 | 36 | 108 | 5 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 1.17e-05 | 39 | 108 | 5 | MP:0030022 | |
| MousePheno | abnormal carbon dioxide production | 1.26e-05 | 67 | 108 | 6 | MP:0008962 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 2.14e-05 | 44 | 108 | 5 | MP:0031023 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 2.97e-05 | 47 | 108 | 5 | MP:0031617 | |
| MousePheno | polyphagia | 3.50e-05 | 80 | 108 | 6 | MP:0001433 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 3.65e-05 | 49 | 108 | 5 | MP:0020948 | |
| MousePheno | decreased cellular glucose uptake | 5.36e-05 | 53 | 108 | 5 | MP:0003926 | |
| MousePheno | increased incidence of induced tumors | 5.76e-05 | 173 | 108 | 8 | MP:0002021 | |
| MousePheno | abnormal fatty acid oxidation | 5.87e-05 | 54 | 108 | 5 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 9.77e-05 | 60 | 108 | 5 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 1.06e-04 | 61 | 108 | 5 | MP:0010951 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.09e-04 | 141 | 108 | 7 | MP:0004499 | |
| MousePheno | abnormal wound healing | 1.24e-04 | 193 | 108 | 8 | MP:0005023 | |
| MousePheno | increased insulin secretion | 1.33e-04 | 64 | 108 | 5 | MP:0003058 | |
| MousePheno | abnormal skeletal muscle morphology | HSPG2 PSG1 PSG3 PSG4 PSG9 EFEMP2 DUSP6 OBSCN RET ZNF106 IGHMBP2 AFG3L2 PSG8 | 1.45e-04 | 508 | 108 | 13 | MP:0000759 |
| MousePheno | abnormal muscle cell glucose uptake | 1.66e-04 | 67 | 108 | 5 | MP:0004130 | |
| MousePheno | abnormal colon morphology | 1.74e-04 | 152 | 108 | 7 | MP:0000495 | |
| MousePheno | abnormal chromatoid body morphology | 1.77e-04 | 3 | 108 | 2 | MP:0031620 | |
| MousePheno | abnormal vascular wound healing | 2.48e-04 | 73 | 108 | 5 | MP:0004883 | |
| MousePheno | ureter stenosis | 3.51e-04 | 4 | 108 | 2 | MP:0003588 | |
| MousePheno | decreased oxygen consumption | 3.59e-04 | 79 | 108 | 5 | MP:0005290 | |
| MousePheno | centrally nucleated skeletal muscle fibers | 3.81e-04 | 80 | 108 | 5 | MP:0009404 | |
| MousePheno | decreased susceptibility to Riboviria infection | 4.27e-04 | 82 | 108 | 5 | MP:0020914 | |
| MousePheno | absent palatal shelf | 5.82e-04 | 5 | 108 | 2 | MP:0009882 | |
| Domain | - | SEMA3F HSPG2 ABI3BP PSG1 PSG3 PSG4 PSG7 PSG9 HLA-F VSIG4 OBSCN BCAN KIRREL2 PKHD1L1 UMODL1 PLXNC1 PSG8 NCR2 IL3RA PALLD ADGRA3 PLXNB3 | 9.18e-10 | 663 | 129 | 22 | 2.60.40.10 |
| Domain | Ig-like_fold | SEMA3F HSPG2 ABI3BP PSG1 PSG3 PSG4 PSG7 PSG9 HLA-F VSIG4 OBSCN BCAN KIRREL2 PKHD1L1 UMODL1 PLXNC1 PSG8 NCR2 IL3RA PALLD ADGRA3 PLXNB3 | 2.93e-09 | 706 | 129 | 22 | IPR013783 |
| Domain | Ig_V-set | HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 VSIG4 OBSCN BCAN KIRREL2 PSG8 NCR2 | 1.35e-08 | 199 | 129 | 12 | IPR013106 |
| Domain | V-set | 6.10e-08 | 184 | 129 | 11 | PF07686 | |
| Domain | ig | SEMA3F HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 VSIG4 OBSCN PSG8 ADGRA3 | 8.47e-08 | 190 | 129 | 11 | PF00047 |
| Domain | Immunoglobulin | SEMA3F HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 VSIG4 OBSCN PSG8 ADGRA3 | 8.47e-08 | 190 | 129 | 11 | IPR013151 |
| Domain | IGc2 | SEMA3F HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 VSIG4 OBSCN KIRREL2 PSG8 PALLD | 8.50e-08 | 235 | 129 | 12 | SM00408 |
| Domain | Ig_sub2 | SEMA3F HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 VSIG4 OBSCN KIRREL2 PSG8 PALLD | 8.50e-08 | 235 | 129 | 12 | IPR003598 |
| Domain | IG | SEMA3F HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 VSIG4 OBSCN BCAN KIRREL2 PSG8 NCR2 PALLD ADGRA3 | 2.21e-07 | 421 | 129 | 15 | SM00409 |
| Domain | Ig_sub | SEMA3F HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 VSIG4 OBSCN BCAN KIRREL2 PSG8 NCR2 PALLD ADGRA3 | 2.21e-07 | 421 | 129 | 15 | IPR003599 |
| Domain | IG_LIKE | SEMA3F HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 HLA-F VSIG4 OBSCN BCAN KIRREL2 PSG8 NCR2 PALLD ADGRA3 | 2.83e-07 | 491 | 129 | 16 | PS50835 |
| Domain | Ig-like_dom | SEMA3F HSPG2 PSG1 PSG3 PSG4 PSG7 PSG9 HLA-F VSIG4 OBSCN BCAN KIRREL2 PSG8 NCR2 PALLD ADGRA3 | 3.91e-07 | 503 | 129 | 16 | IPR007110 |
| Domain | Ig_2 | 7.10e-07 | 73 | 129 | 7 | PF13895 | |
| Domain | EGF_3 | 2.30e-04 | 235 | 129 | 8 | PS50026 | |
| Domain | EGF-like_dom | 3.40e-04 | 249 | 129 | 8 | IPR000742 | |
| Domain | GPCR_2_secretin-like | 7.85e-04 | 60 | 129 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 7.85e-04 | 60 | 129 | 4 | IPR017981 | |
| Domain | IPT | 8.34e-04 | 27 | 129 | 3 | SM00429 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 8.36e-04 | 61 | 129 | 4 | PS50261 | |
| Domain | TLV_coat | 9.72e-04 | 7 | 129 | 2 | PF00429 | |
| Domain | EGF | 1.24e-03 | 235 | 129 | 7 | SM00181 | |
| Domain | Semap_dom | 1.26e-03 | 31 | 129 | 3 | IPR001627 | |
| Domain | SEMA | 1.26e-03 | 31 | 129 | 3 | PS51004 | |
| Domain | TIG | 1.26e-03 | 31 | 129 | 3 | PF01833 | |
| Domain | Sema | 1.26e-03 | 31 | 129 | 3 | SM00630 | |
| Domain | Sema | 1.26e-03 | 31 | 129 | 3 | PF01403 | |
| Domain | TLV/ENV_coat_polyprotein | 1.29e-03 | 8 | 129 | 2 | IPR018154 | |
| Domain | IPT | 1.38e-03 | 32 | 129 | 3 | IPR002909 | |
| Domain | EGF_CA | 1.58e-03 | 122 | 129 | 5 | SM00179 | |
| Domain | Plexin_cytopl | 1.65e-03 | 9 | 129 | 2 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.65e-03 | 9 | 129 | 2 | IPR013548 | |
| Domain | Plexin | 1.65e-03 | 9 | 129 | 2 | IPR031148 | |
| Domain | EGF-like_Ca-bd_dom | 1.70e-03 | 124 | 129 | 5 | IPR001881 | |
| Domain | IGv | 1.81e-03 | 75 | 129 | 4 | SM00406 | |
| Domain | EGF_1 | 1.98e-03 | 255 | 129 | 7 | PS00022 | |
| Domain | Ig_I-set | 2.07e-03 | 190 | 129 | 6 | IPR013098 | |
| Domain | I-set | 2.07e-03 | 190 | 129 | 6 | PF07679 | |
| Domain | EGF-like_CS | 2.26e-03 | 261 | 129 | 7 | IPR013032 | |
| Domain | LAM_G_DOMAIN | 2.28e-03 | 38 | 129 | 3 | PS50025 | |
| Domain | EGF_2 | 2.46e-03 | 265 | 129 | 7 | PS01186 | |
| Domain | Frizzled | 2.50e-03 | 11 | 129 | 2 | IPR000539 | |
| Domain | Frizzled | 2.50e-03 | 11 | 129 | 2 | PF01534 | |
| Domain | Laminin_G_1 | 2.50e-03 | 11 | 129 | 2 | PF00054 | |
| Domain | Frizzled | 2.50e-03 | 11 | 129 | 2 | SM01330 | |
| Domain | Laminin_G_2 | 2.64e-03 | 40 | 129 | 3 | PF02210 | |
| Domain | Coagulation_fac_subgr_Gla_dom | 2.99e-03 | 12 | 129 | 2 | IPR017857 | |
| Domain | - | 2.99e-03 | 12 | 129 | 2 | 4.10.740.10 | |
| Domain | PSI | 3.47e-03 | 44 | 129 | 3 | IPR016201 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.93e-03 | 46 | 129 | 3 | IPR011042 | |
| Domain | PSI | 3.93e-03 | 46 | 129 | 3 | SM00423 | |
| Domain | ZP_2 | 4.08e-03 | 14 | 129 | 2 | PS51034 | |
| Domain | GLA_1 | 4.08e-03 | 14 | 129 | 2 | PS00011 | |
| Domain | GLA_2 | 4.08e-03 | 14 | 129 | 2 | PS50998 | |
| Domain | ZP_1 | 4.08e-03 | 14 | 129 | 2 | PS00682 | |
| Domain | Gla | 4.08e-03 | 14 | 129 | 2 | PF00594 | |
| Domain | TUDOR | 4.08e-03 | 14 | 129 | 2 | PF00567 | |
| Domain | GLA | 4.08e-03 | 14 | 129 | 2 | SM00069 | |
| Domain | GLA_domain | 4.08e-03 | 14 | 129 | 2 | IPR000294 | |
| Domain | EGF_Ca-bd_CS | 4.59e-03 | 97 | 129 | 4 | IPR018097 | |
| Domain | ZP | 4.69e-03 | 15 | 129 | 2 | SM00241 | |
| Domain | EGF_CA | 4.93e-03 | 99 | 129 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.11e-03 | 100 | 129 | 4 | PS00010 | |
| Domain | Ald_DH_CS_GLU | 5.33e-03 | 16 | 129 | 2 | IPR029510 | |
| Domain | Frizzled/SFRP | 5.33e-03 | 16 | 129 | 2 | IPR015526 | |
| Domain | ZP_dom | 6.02e-03 | 17 | 129 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 6.02e-03 | 17 | 129 | 2 | PF00100 | |
| Domain | Ald_DH_CS_CYS | 6.02e-03 | 17 | 129 | 2 | IPR016160 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.27e-03 | 106 | 129 | 4 | IPR000152 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 6.74e-03 | 18 | 129 | 2 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 6.74e-03 | 18 | 129 | 2 | PS00687 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 9.16e-10 | 13 | 132 | 5 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 9.16e-10 | 13 | 132 | 5 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 9.16e-10 | 13 | 132 | 5 | 16638824 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 20044046 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 32150576 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 6265583 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 9.16e-10 | 13 | 132 | 5 | 12832451 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 9.16e-10 | 13 | 132 | 5 | 21670291 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 22162753 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 2702644 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 8380065 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 1279194 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 25724769 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 9.16e-10 | 13 | 132 | 5 | 22092845 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 11801635 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 9.16e-10 | 13 | 132 | 5 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 9.16e-10 | 13 | 132 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 9.16e-10 | 13 | 132 | 5 | 23800882 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 19285068 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 21760897 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 9.16e-10 | 13 | 132 | 5 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 9.16e-10 | 13 | 132 | 5 | 39168268 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 8402684 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 16619040 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 9.16e-10 | 13 | 132 | 5 | 8209741 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 9.16e-10 | 13 | 132 | 5 | 21949477 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 26219866 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 2133556 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 32521208 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 19406938 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 9.16e-10 | 13 | 132 | 5 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 9.16e-10 | 13 | 132 | 5 | 19358828 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 16680193 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 9.16e-10 | 13 | 132 | 5 | 34058224 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 10964771 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 32169849 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 9.16e-10 | 13 | 132 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 9.16e-10 | 13 | 132 | 5 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 9.16e-10 | 13 | 132 | 5 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 9.16e-10 | 13 | 132 | 5 | 23935487 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 15331748 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 9.16e-10 | 13 | 132 | 5 | 22406619 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 9.16e-10 | 13 | 132 | 5 | 25972571 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 19008452 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 9.16e-10 | 13 | 132 | 5 | 15220458 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 18843289 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 15207636 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 21081647 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 11133662 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 11483763 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 2164599 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 29396368 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 18003729 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 9.16e-10 | 13 | 132 | 5 | 33352461 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 38381498 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 20739537 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 9.16e-10 | 13 | 132 | 5 | 27695943 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 20404914 | ||
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 9.16e-10 | 13 | 132 | 5 | 32027621 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 9.16e-10 | 13 | 132 | 5 | 27777319 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 18848945 | ||
| Pubmed | 9.38e-10 | 28 | 132 | 6 | 8672132 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.42e-09 | 14 | 132 | 5 | 34666041 | |
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 1.42e-09 | 14 | 132 | 5 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 1.42e-09 | 14 | 132 | 5 | 32209360 | |
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 11994468 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 11850617 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 1.42e-09 | 14 | 132 | 5 | 26196244 | |
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 8896983 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 22962327 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 17623671 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.42e-09 | 14 | 132 | 5 | 18794798 | |
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 23469261 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 18454175 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 22159884 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 29907459 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 36719377 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 23780386 | ||
| Pubmed | 1.42e-09 | 14 | 132 | 5 | 28567513 | ||
| Interaction | PSG4 interactions | 1.10e-07 | 8 | 129 | 4 | int:PSG4 | |
| Interaction | PSG3 interactions | 1.07e-05 | 22 | 129 | 4 | int:PSG3 | |
| Interaction | PSG1 interactions | 1.84e-05 | 51 | 129 | 5 | int:PSG1 | |
| Interaction | MGRN1 interactions | 2.45e-05 | 90 | 129 | 6 | int:MGRN1 | |
| Cytoband | 19q13.2 | 5.29e-07 | 164 | 132 | 7 | 19q13.2 | |
| Cytoband | 6q16.1-q16.3 | 2.46e-05 | 3 | 132 | 2 | 6q16.1-q16.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ERVV-2 PSG1 PSG3 PSG4 PSG7 PSG9 KIRREL2 HNRNPL CGB2 ERVV-1 PSG8 | 6.87e-04 | 1192 | 132 | 11 | chr19q13 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 5.43e-12 | 11 | 89 | 6 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.40e-06 | 163 | 89 | 8 | 590 | |
| GeneFamily | Plexins | 8.43e-04 | 9 | 89 | 2 | 683 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.20e-03 | 161 | 89 | 5 | 593 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.28e-03 | 11 | 89 | 2 | 286 | |
| GeneFamily | Gla domain containing | 1.80e-03 | 13 | 89 | 2 | 1250 | |
| GeneFamily | Cadherin related | 3.11e-03 | 17 | 89 | 2 | 24 | |
| GeneFamily | Aldehyde dehydrogenases | 3.88e-03 | 19 | 89 | 2 | 398 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 4.12e-08 | 102 | 129 | 8 | M10290 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 2.41e-07 | 128 | 129 | 8 | MM1000 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 4.83e-07 | 32 | 129 | 5 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 7.70e-07 | 35 | 129 | 5 | MM757 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 3.86e-06 | 48 | 129 | 5 | MM531 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | PSG1 PSG3 PSG4 PSG9 DUSP6 HLA-F DRAM2 COL24A1 RAB3IP PSG8 ANXA9 PROS1 | 5.77e-06 | 490 | 129 | 12 | MM1001 |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 6.79e-06 | 93 | 129 | 6 | M40279 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 7.18e-06 | 201 | 129 | 8 | MM1006 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.50e-05 | 75 | 129 | 5 | MM605 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | HSPG2 HLA-F TUT1 PTCH1 FZD7 CDAN1 GJB3 EFNB1 GLB1 ADGRL2 FZD2 SLC9A6 ADGRA3 | 4.52e-05 | 703 | 129 | 13 | MM1055 |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | LEMD3 DUSP6 SH2D3A ZNF217 BTBD2 FZD7 MRPS30 GJB3 ALDH3A1 ANXA9 PROS1 | 4.75e-05 | 512 | 129 | 11 | M4508 |
| Coexpression | DURAND_STROMA_NS_UP | 5.10e-05 | 194 | 129 | 7 | MM962 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 5.99e-05 | 199 | 129 | 7 | M8111 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 7.15e-05 | 87 | 129 | 5 | MM851 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 1.19e-04 | 568 | 129 | 11 | MM3824 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 1.29e-04 | 302 | 129 | 8 | MM16604 | |
| Coexpression | NABA_MATRISOME | SEMA3F HSPG2 ABI3BP CTSC EFEMP2 BCAN ZP3 F9 COL24A1 FSTL1 PLXNC1 PLG ANXA9 PLXNB3 OTOG | 1.34e-04 | 1008 | 129 | 15 | MM17056 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.39e-04 | 159 | 129 | 6 | MM760 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | HSPG2 TUT1 PTCH1 FZD7 CDAN1 GJB3 EFNB1 GLB1 ADGRL2 FZD2 SLC9A6 ADGRA3 | 1.41e-04 | 681 | 129 | 12 | M5314 |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 189 | 132 | 7 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | droplet-Lung-21m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-06 | 193 | 132 | 7 | 3a5ad8ffad441e30a6e1bd017da7720ad57f6c57 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 195 | 132 | 7 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.92e-06 | 195 | 132 | 7 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 197 | 132 | 7 | fd76cc5e12c7e7943a48f739e4f0626ff7211f51 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-06 | 198 | 132 | 7 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.20e-06 | 199 | 132 | 7 | 80c8641cfd84436eadf2234f1313749e2f73331f | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.04e-06 | 159 | 132 | 6 | 2f6c60ddff2208a68146f9786143d9aefd528840 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.04e-06 | 159 | 132 | 6 | ded4e3626a62fb6334403b7213b467fb7e8131c3 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-05 | 166 | 132 | 6 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-05 | 167 | 132 | 6 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-05 | 167 | 132 | 6 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.22e-05 | 171 | 132 | 6 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 172 | 132 | 6 | 910ec7794ea4000db4ef1e2c34e08dbc0243df2c | |
| ToppCell | Influenza_Severe-Plasmablast|Influenza_Severe / Disease group and Cell class | 1.39e-05 | 175 | 132 | 6 | 3f9b9793d3d1b7a9b97899272b6a0d37b05c11d1 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-05 | 180 | 132 | 6 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 181 | 132 | 6 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 184 | 132 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 184 | 132 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 184 | 132 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 1.90e-05 | 185 | 132 | 6 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 186 | 132 | 6 | 9d6cb36aa0aae69fe584dad31deafcfdcc9fd1db | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.96e-05 | 186 | 132 | 6 | cacc2f0b2ed46516173b61ba1c5c226a2db7cddc | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-05 | 188 | 132 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-05 | 189 | 132 | 6 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 2.27e-05 | 191 | 132 | 6 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-05 | 192 | 132 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-05 | 192 | 132 | 6 | 6c089bde63dd5f16a07c5929fb49df600f0b21ab | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 192 | 132 | 6 | f094ac378e635cf5820e8a8b7a0152073a51ceae | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-05 | 193 | 132 | 6 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 193 | 132 | 6 | ffdcbc5caff7fd4cc2e83dd21a05d43b0593d542 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.41e-05 | 193 | 132 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.41e-05 | 193 | 132 | 6 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | droplet-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.41e-05 | 193 | 132 | 6 | 25129080f8a40b2988a5d9dfec36ff9e72c27e61 | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-05 | 194 | 132 | 6 | cf7f232827945fbafd2c298c08a799ab916c2472 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 194 | 132 | 6 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-05 | 194 | 132 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 194 | 132 | 6 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.63e-05 | 196 | 132 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-05 | 196 | 132 | 6 | a7adc0e0baef261d0937e4e8351321d41beca82f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-05 | 196 | 132 | 6 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 197 | 132 | 6 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 197 | 132 | 6 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 2.70e-05 | 197 | 132 | 6 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 197 | 132 | 6 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.70e-05 | 197 | 132 | 6 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 197 | 132 | 6 | 888f3b14133e078570ce4ad73d9a9ee3137f9cac | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.70e-05 | 197 | 132 | 6 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 198 | 132 | 6 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.78e-05 | 198 | 132 | 6 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 198 | 132 | 6 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 198 | 132 | 6 | 75d104eead681f6bf47c4dd24913cc768c9a1717 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-05 | 199 | 132 | 6 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 199 | 132 | 6 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-05 | 199 | 132 | 6 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.86e-05 | 199 | 132 | 6 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.86e-05 | 199 | 132 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 199 | 132 | 6 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.86e-05 | 199 | 132 | 6 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.86e-05 | 199 | 132 | 6 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-05 | 199 | 132 | 6 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.86e-05 | 199 | 132 | 6 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-05 | 199 | 132 | 6 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-05 | 199 | 132 | 6 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 200 | 132 | 6 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 200 | 132 | 6 | 1801f10910aea899269025f24d1ca2d62168c6a6 | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 200 | 132 | 6 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 200 | 132 | 6 | c0ea7cbc9d5e999530888145ce9e4c232fc874de | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.33e-05 | 136 | 132 | 5 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 156 | 132 | 5 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 156 | 132 | 5 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-04 | 158 | 132 | 5 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.22e-04 | 162 | 132 | 5 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | BAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.25e-04 | 163 | 132 | 5 | 7047d3ba847930f42a6d5f71e18d49f3071c6409 | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.36e-04 | 166 | 132 | 5 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.36e-04 | 166 | 132 | 5 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 167 | 132 | 5 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.44e-04 | 168 | 132 | 5 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 169 | 132 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 170 | 132 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.52e-04 | 170 | 132 | 5 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 171 | 132 | 5 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-04 | 172 | 132 | 5 | c3a99828838af3b85c8c885d69cc8018f55ced50 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.61e-04 | 172 | 132 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 172 | 132 | 5 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 173 | 132 | 5 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 173 | 132 | 5 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 173 | 132 | 5 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-04 | 174 | 132 | 5 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 176 | 132 | 5 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 176 | 132 | 5 | 3494ffa8555e6edf4b1250e10434bae9b73ec845 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 176 | 132 | 5 | d43f6b7828b98e1dab7b726a5f99499d65a7db80 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 177 | 132 | 5 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-04 | 177 | 132 | 5 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 178 | 132 | 5 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.94e-04 | 179 | 132 | 5 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasmablasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.94e-04 | 179 | 132 | 5 | 58c8996120637315dcbd1991a71516c09173051e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-04 | 179 | 132 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 180 | 132 | 5 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-04 | 180 | 132 | 5 | d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab | |
| Computational | Neighborhood of CDKN1C | 1.52e-06 | 27 | 81 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 3.68e-06 | 32 | 81 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 5.83e-06 | 35 | 81 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.47e-05 | 42 | 81 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.31e-05 | 46 | 81 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 3.15e-05 | 49 | 81 | 5 | GNF2_KISS1 | |
| Drug | AC1L1IPV | 1.51e-07 | 43 | 129 | 6 | CID000004683 | |
| Drug | Rgd Peptide | 9.15e-06 | 239 | 129 | 9 | CID000104802 | |
| Drug | lixazinone | 9.75e-06 | 8 | 129 | 3 | CID000058573 | |
| Drug | D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 6782_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 6832_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 6777_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 6036_UP | |
| Disease | cD177 antigen measurement | 1.03e-08 | 18 | 125 | 5 | EFO_0021866 | |
| Disease | Congenital dyserythropoietic anemia, type I | 1.78e-05 | 2 | 125 | 2 | cv:C0271933 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 1.06e-04 | 4 | 125 | 2 | EFO_0801909 | |
| Disease | Congenital dyserythropoietic anemia, type I | 1.06e-04 | 4 | 125 | 2 | C0271933 | |
| Disease | Congenital dyserythropoietic anemia, type II | 1.06e-04 | 4 | 125 | 2 | C1306589 | |
| Disease | Congenital dyserythropoietic anemia, type III | 1.77e-04 | 5 | 125 | 2 | C0271934 | |
| Disease | Congenital dyserythropoietic anemia | 1.77e-04 | 5 | 125 | 2 | C0002876 | |
| Disease | breast carcinoma (is_marker_for) | 1.81e-04 | 66 | 125 | 4 | DOID:3459 (is_marker_for) | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 2.64e-04 | 6 | 125 | 2 | EFO_0801907 | |
| Disease | Congenital dyserythropoietic anemia | 2.64e-04 | 6 | 125 | 2 | cv:C0002876 | |
| Disease | brain ischemia (biomarker_via_orthology) | 9.47e-04 | 102 | 125 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | PR domain zinc finger protein 1 measurement | 9.55e-04 | 11 | 125 | 2 | EFO_0801904 | |
| Disease | hyperglycemia (is_marker_for) | 1.35e-03 | 13 | 125 | 2 | DOID:4195 (is_marker_for) | |
| Disease | monokine induced by gamma interferon measurement | 1.41e-03 | 52 | 125 | 3 | EFO_0008236 | |
| Disease | serum IgG glycosylation measurement | 1.78e-03 | 523 | 125 | 8 | EFO_0005193 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.05e-03 | 16 | 125 | 2 | C0038015 | |
| Disease | coronary thrombosis, GM11992 | 2.05e-03 | 16 | 125 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 2.05e-03 | 16 | 125 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 2.05e-03 | 16 | 125 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 2.05e-03 | 16 | 125 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 2.05e-03 | 16 | 125 | 2 | C0025237 | |
| Disease | Van Buchem disease | 2.32e-03 | 17 | 125 | 2 | C0432272 | |
| Disease | Osteochondrodysplasias | 2.90e-03 | 19 | 125 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 2.90e-03 | 19 | 125 | 2 | C0013366 | |
| Disease | synophrys measurement | 3.04e-03 | 68 | 125 | 3 | EFO_0007906 | |
| Disease | Deaf Mutism | 3.22e-03 | 20 | 125 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 3.22e-03 | 20 | 125 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 3.22e-03 | 20 | 125 | 2 | C0086395 | |
| Disease | Multiple Epiphyseal Dysplasia | 3.22e-03 | 20 | 125 | 2 | C0026760 | |
| Disease | Complete Hearing Loss | 3.22e-03 | 20 | 125 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 3.22e-03 | 20 | 125 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 3.22e-03 | 20 | 125 | 2 | C0011052 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 3.30e-03 | 70 | 125 | 3 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.34e-03 | 144 | 125 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.42e-03 | 145 | 125 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | osteoporosis | 3.72e-03 | 73 | 125 | 3 | EFO_0003882 | |
| Disease | cognitive function measurement, self reported educational attainment | 4.12e-03 | 355 | 125 | 6 | EFO_0004784, EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DCPPVSDYVVLNVTS | 311 | Q5DID0 | |
| DYGNIETLPLCRVQP | 1026 | Q9BXT4 | |
| QTYCDAILQIPELSP | 691 | P83436 | |
| SQQELRAPCLPVTYQ | 331 | O43683 | |
| ALYNPIPVRQNCFTV | 51 | Q15878 | |
| QSDPACCPVYIQRAV | 2396 | Q68DQ2 | |
| CCPVYIQRAVPNLEE | 2401 | Q68DQ2 | |
| ITTYCPANNEPIARV | 66 | P49419 | |
| TDIIAAYQRFCSRPP | 56 | Q9Y4W6 | |
| YCVPVIQRTQPSAEL | 216 | Q9C0J9 | |
| TSVRPAAQPEICYQL | 296 | Q9Y574 | |
| YDPSCTSPVALQRAI | 301 | P35670 | |
| DTRCVYPKSLQAQPV | 211 | Q8IWK6 | |
| VLESSAQYCPPERVV | 341 | Q8IWK6 | |
| APDYILCDPSIQNQI | 246 | P30838 | |
| PYNTLLAETVVCNAP | 1186 | O95490 | |
| STPPVANLYTCINNI | 276 | B6SEH9 | |
| RPCVYTVGSPINNRA | 266 | Q8N6M6 | |
| DATCVVIRSQYVPTP | 456 | O94850 | |
| QPLYSPVCTNGERFL | 231 | Q6W2J9 | |
| NAPVVDQQLLYTCCP | 786 | Q8IWY9 | |
| DPRCISVIGYQPQDL | 351 | Q9HBZ2 | |
| SLCTVDQRPESYNPN | 306 | O75355 | |
| PAVEPTDQAQYLCRA | 1921 | P98160 | |
| RIPQVTPADSGEYVC | 2586 | P98160 | |
| TQPVYSSPRRLNCAE | 81 | Q96QF0 | |
| AAVVVPPGEEQRYTC | 266 | P30511 | |
| CDQVDSSPVPRYRVN | 346 | Q9Y2U8 | |
| YTVNDNARCIPIFPR | 176 | Q9NPB9 | |
| QTVRYPIQTPREACY | 211 | Q96GW7 | |
| AQCSIKQERISYTPP | 6 | P41212 | |
| RSYKPQRVVITCPQD | 2031 | Q14676 | |
| VAGQTLTVRCQYPPT | 31 | O95944 | |
| ATPDAVRIQICPFEN | 186 | Q6ZVW7 | |
| VPQFCDSLPRYETTQ | 291 | Q92831 | |
| QPIVYTPEDCRKAFQ | 701 | Q8NI77 | |
| VLYRTTLPQDCSNPA | 416 | P16278 | |
| STPPVANLYTCINNI | 276 | B6SEH8 | |
| PVCTATTYNVADPRR | 171 | Q9BZM3 | |
| DVQYAVSVASRPCNP | 866 | Q9ULL4 | |
| ATYVLPEPETASRCN | 181 | O60486 | |
| LYDTAPCPINNERTR | 246 | Q6UX65 | |
| YRLAENQKSCEPAVP | 161 | P00740 | |
| ICNELSQPVTFPVRA | 191 | Q6UXP7 | |
| PISIPLCTDIAYNQT | 41 | Q14332 | |
| TPVPVLAAQRDYCSK | 166 | Q8NGI3 | |
| VEAQYIQAQAREPPC | 66 | Q86UY5 | |
| ATRTPPQLQECLAVY | 141 | O76027 | |
| AILTFRLPYCGPNQV | 161 | Q8NGC4 | |
| NSVANPVLYVLTCPD | 296 | Q9Y5Y4 | |
| QFTCTIEGAPYPQIR | 6126 | Q5VST9 | |
| VPVQQVHSPTSYLCR | 416 | Q8WX93 | |
| QIRCYSAPVAAEPFL | 36 | Q02218 | |
| VPNTRDCRPLTYQAA | 271 | Q96QU1 | |
| VLPALPQVVCNYRDV | 66 | Q6NT52 | |
| PISIPLCTDIAYNQT | 51 | O75084 | |
| YRQNIPASELPVAVT | 616 | Q96EP1 | |
| CEVTNYTVRVANPPF | 76 | P26951 | |
| CTQFPYREDQPNITS | 631 | P0C671 | |
| EVQAESSNYPCLVPV | 26 | P22748 | |
| AQYDEIAQCLVSVPP | 6 | Q9Y2V0 | |
| VIRILACSANPYSPN | 151 | Q9UKA2 | |
| LEQVQACFSRPPSVV | 86 | Q92506 | |
| PSASPVVCYQSNRDE | 106 | Q12841 | |
| DIIIPLRTTENNYCP | 301 | P98172 | |
| PILSPQEVVSCSQYA | 281 | P53634 | |
| AVYTDIPAPEAARQC | 91 | P31276 | |
| DRGEPTQVCYLQRPI | 396 | O75426 | |
| LYTICNPCGPVQRIV | 211 | P14866 | |
| FLCQATAQPPVTGYR | 246 | Q6UWL6 | |
| QIPSRAPQCVFGYTT | 221 | Q9BZJ6 | |
| QRLPSETIQTYPRSC | 61 | Q9NPI7 | |
| ETIQTYPRSCNIPQT | 66 | Q9NPI7 | |
| YPRSCNIPQTVENRL | 71 | Q9NPI7 | |
| PADRRANYPVFCVQT | 61 | Q9BYW3 | |
| CPTQYTTERFPDNSI | 916 | Q5T890 | |
| VEPYIQVSENRCLCP | 316 | O95967 | |
| PVEVLPNVNYTACAT | 456 | Q9BX70 | |
| NVAPCPNIVDCYIAR | 166 | O75712 | |
| SPCDNRVPAQQLYFT | 351 | Q16828 | |
| ILPNVTRNETGPYQC | 296 | Q00888 | |
| PNLNVVDGRLTYPTC | 511 | Q6UVJ0 | |
| TIPYTAPEVCQAGRA | 211 | Q52WX2 | |
| LIRPCYVQATALQSP | 1176 | Q6ZTR5 | |
| AVECVPYTQALTPAT | 151 | O95396 | |
| ILPSVTRNETGPYQC | 296 | P11464 | |
| VNPVYDCLFRLAQPD | 126 | A9UHW6 | |
| TLTFRLPYCGPNQVD | 166 | Q8NGC3 | |
| ILPSVTRNETGPYQC | 296 | Q16557 | |
| PTPQVLDEVTQRCVY | 1446 | Q6ZRI0 | |
| ALQDPTILQATCPYS | 211 | Q6NXP6 | |
| DSPLRYVDIAIPCNN | 151 | P08865 | |
| TTCQDVAATPVARYP | 31 | Q9NP92 | |
| RPPTAQEVCYLRAQQ | 686 | Q8N1G1 | |
| EQVADRRNCIPCPYI | 1556 | O60522 | |
| QPENIATCIALRPYP | 111 | Q6GMV3 | |
| GPIARCLTSPQAYEN | 566 | Q92581 | |
| AAFLECQPRSPQATV | 621 | Q13275 | |
| TVLCEQYQPSLRRDP | 256 | Q7L5D6 | |
| CVNYVPEPENSALLR | 236 | Q13200 | |
| QNVYVCTGPLFLPRT | 191 | Q14249 | |
| ILPSVTRNETGPYQC | 296 | Q9UQ74 | |
| ILPSVTRNETGPYQC | 296 | Q00887 | |
| SPCVSRVIQVEPQAY | 616 | Q13635 | |
| EVYRLPPQKEETQSC | 476 | Q96EA4 | |
| NSPSVAPYCTRSQRV | 61 | Q9BXF9 | |
| ILPSVTRNETGPYQC | 296 | Q13046 | |
| YNVGPENPSRICIVI | 216 | Q68CZ2 | |
| LPSPNYVVADRTECF | 686 | P00747 | |
| AYPDLRSCVNAIPDQ | 106 | P07225 | |
| PETYRACVARNPVIN | 601 | P13798 | |
| QCRQADKYQPETSIP | 241 | Q17RW2 | |
| CGTPNYVAPEVLLRQ | 221 | Q9H4B4 | |
| PQETVLRVPVSKYQC | 3386 | Q86UP3 | |
| PLASPVENKEVYQCR | 711 | Q9ULJ3 | |
| PTIIERSVQPCDNYI | 311 | Q9NXC5 | |
| PSLVYEAVCNRQNRP | 226 | Q9Y572 | |
| YCELVPRVPSVQGTS | 231 | Q9BRG2 | |
| PARDIAVVSPYNLQV | 531 | P38935 | |
| CVPGVYRVQTVPSAR | 351 | Q9H6E5 | |
| YCRGLPDPQDIISQS | 811 | Q9P273 | |
| VPLDSYRCQLFIQPA | 2581 | Q709C8 | |
| VDCPYPLSQITARNN | 931 | O15040 | |
| QIISINPNEVYCRTP | 1871 | Q86WI1 | |
| ISLQCQARGSPPISY | 161 | Q9Y279 | |
| DDPKITIVSCNPNYR | 711 | Q8TE23 | |
| LPVQFLCPNISVAYR | 191 | P07949 | |
| ITSLLPQDCVYPSQA | 951 | O75362 | |
| QDVRNCSTNPPYLPV | 31 | O43895 | |
| VRYIQKPDNSPCSIT | 796 | Q7Z7G0 | |
| VPYATINTSCRPATL | 231 | Q6DKI7 | |
| PVPVILNFDAECQRT | 171 | A4D1P6 | |
| IPIECRYPRQGNVSS | 136 | P21754 | |
| NREISDSCPVYPVIT | 1231 | Q9H2Y7 | |
| EPPTACREKQYLINS | 21 | P25942 | |
| GCNPQLTYTATLPER | 1561 | Q70EL1 | |
| YCPIPARKNSTAAEV | 31 | B2RTY4 |